You are not currently logged in.
Access JSTOR through your library or other institution:
Efficacy of Recombinant Glycoprotein D Subunit Vaccines on the Development of Primary, Recurrent, and Latent Genital Infections with Herpes Simplex Virus Type 2 in Guinea Pigs
Phillip W. Berman, Peggy E. Vogt, Timothy Gregory, Laurence A. Lasky and Earl R. Kern
The Journal of Infectious Diseases
Vol. 157, No. 5 (May, 1988), pp. 897-902
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/30135689
Page Count: 6
You can always find the topics here!Topics: Vaccination, Infections, Human herpesvirus 2, Viruses, Lesions, Glycoproteins, Genitalia, Placebos, Human herpesvirus 1, Simplexvirus
Were these topics helpful?See something inaccurate? Let us know!
Select the topics that are inaccurate.
Preview not available
Vaccination of guinea pigs with recombinant glycoprotein D (subunit vaccine) from either herpes simplex virus type 1 or type 2 (HSV-1, HSV-2), before intravaginal inoculation with HSV-2, markedly altered viral replication in the vaginal tract and reduced, or completely prevented, the development and spread of external genital lesions. Vaccination with glycoprotein D from HSV-2 prevented the establishment of latent HSV-2 infections in dorsal root ganglia and reduced the frequency of recurrent episodes. For all parameters of efficacy that we tested, vaccination with glycoprotein D from HSV-2 was more effective than was vaccination with protein derived from HSV-1. Vaccination after primary infection had no effect on the frequency or duration of recurrent HSV-2 infections.
The Journal of Infectious Diseases © 1988 Oxford University Press